Applied Molecular Transport Inc. (AMTI) News

Applied Molecular Transport Inc. (AMTI): $2.90

-0.01 (-0.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AMTI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Filter AMTI News Items

AMTI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AMTI News Highlights

  • AMTI's 30 day story count now stands at 2.
  • Over the past 14 days, the trend for AMTI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • AMT are the most mentioned tickers in articles about AMTI.

Latest AMTI News From Around the Web

Below are the latest news stories about Applied Molecular Transport Inc that investors may wish to consider to help them evaluate AMTI as an investment opportunity.

Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Four top-line data readouts expected in 2022 from ongoing oral AMT-101 Phase 2 trials, as follows FILLMORE monotherapy trial for patients with chronic pouchitis followed by MARKET combination trial with anti-TNFα in ulcerative colitis (UC) in H1 2022LOMBARD monotherapy trial in UC and CASTRO combination trial with anti-TNFα in rheumatoid arthritis (RA) in H2 2022 Phase 1 ongoing for second product candidate, oral AMT-126, with program update in H1 2022 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022

Yahoo | February 24, 2022

Applied Molecular Transport to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the SVB Leerink Virtual 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 1:00 p.m. ET. A live webcast will be accessible via the Events page of the Applied Molecular Transport website at

Yahoo | February 10, 2022

Applied Molecular Transport Announces Board Appointments

John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead Independent Director SOUTH SAN FRANCISCO, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of John W. Smither to its Board of Directors and Chair of its Audit Committee. AMT also announced that current Director, Graham K. Cooper,

Yahoo | January 27, 2022

Applied Molecular Transport (NASDAQ:AMTI) Trading Down 3.4%

Applied Molecular Transport Inc. (NASDAQ:AMTI)s stock price traded down 3.4% during trading on Tuesday . The company traded as low as $13.29 and last traded at $13.41. 2,387 shares changed hands during trading, a decline of 99% from the average session volume of 439,193 shares. The stock had previously closed at $13.88. Several research analysts []

Transcript Daily | December 23, 2021

Applied Molecular Transport (NASDAQ:AMTI) Hits New 12-Month Low at $13.99

Applied Molecular Transport Inc. (NASDAQ:AMTI)s stock price reached a new 52-week low during trading on Monday . The company traded as low as $13.99 and last traded at $14.25, with a volume of 11000 shares trading hands. The stock had previously closed at $14.42. A number of research analysts have issued reports on the stock. []

Dakota Financial News | December 15, 2021

Applied Molecular Transport Inc. (NASDAQ:AMTI) Insider Randall Ph.D. Mrsny Buys 3,500 Shares

Applied Molecular Transport Inc. (NASDAQ:AMTI) insider Randall Ph.D. Mrsny bought 3,500 shares of Applied Molecular Transport stock in a transaction that occurred on Thursday, December 9th. The shares were acquired at an average price of $14.99 per share, for a total transaction of $52,465.00. The acquisition was disclosed in a legal filing with the SEC, []

Dakota Financial News | December 11, 2021

Applied Molecular Transport (NASDAQ:AMTI) Shares Gap Up to $14.43

Applied Molecular Transport Inc. (NASDAQ:AMTI)s share price gapped up prior to trading on Tuesday . The stock had previously closed at $14.43, but opened at $16.01. Applied Molecular Transport shares last traded at $14.87, with a volume of 245 shares changing hands. AMTI has been the subject of several recent research reports. Jefferies Financial Group []

Dakota Financial News | December 9, 2021

Applied Molecular Transport (NASDAQ:AMTI) Hits New 12-Month Low at $14.41

Applied Molecular Transport Inc. (NASDAQ:AMTI)s share price hit a new 52-week low during trading on Monday . The stock traded as low as $14.41 and last traded at $14.59, with a volume of 525 shares trading hands. The stock had previously closed at $14.84. A number of research analysts have recently weighed in on AMTI []

Transcript Daily | December 6, 2021

Applied Molecular Transport Inc. (AMTI): Worth A Small Bite At $14.84

Applied Molecular Transport Inc. (NASDAQ:AMTI) concluded the trading at $14.84 on Friday, December 03 with a fall of -7.77% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $16.09 with its price kept floating in the range of $14.50 and $16.14 on Applied Molecular Transport Inc. (AMTI): Worth A Small Bite At $14.84 Read More »

Stocks Register | December 4, 2021

Marshall Wace LLP Acquires New Stake in Applied Molecular Transport Inc. (NASDAQ:AMTI)

Marshall Wace LLP bought a new position in shares of Applied Molecular Transport Inc. (NASDAQ:AMTI) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 8,441 shares of the companys stock, valued at approximately $386,000. Several other institutional investors have also added to or reduced their stakes in AMTI. FMR LLC acquired a new stake []

Transcript Daily | November 30, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.415 seconds.